Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
1.050
+0.020 (1.94%)
Dec 5, 2025, 4:00 PM EST - Market closed
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $111.91 million as of December 5, 2025. Its market cap has decreased by -15.72% in one year.
Market Cap
111.91M
Enterprise Value
35.12M
1-Year Change
-15.72%
Ranking
Category
Stock Price
$1.05
Market Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has increased from $51.03M to $111.91M, an increase of 119.32%. That is a compound annual growth rate of 20.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 99.95M | 18.27% |
| Dec 31, 2024 | 84.51M | 368.39% |
| Dec 29, 2023 | 18.04M | 73.39% |
| Dec 30, 2022 | 10.41M | -75.50% |
| Dec 31, 2021 | 42.47M | -16.77% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |